Stockreport

Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]

Sionna Therapeutics, Inc.  (SION) 
PDF of care in participants with cystic fibrosis is on track with topline data anticipated in mid-2026 Ongoing Phase 1 trial evaluating NBD1 stabilizer SION-451 in proprie [Read more]